NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 16 filers reported holding NOVABAY PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $4,000 | -91.7% | 15,738 | -90.4% | 0.00% | -100.0% |
Q1 2022 | $48,000 | +182.4% | 163,451 | +260.4% | 0.00% | +100.0% |
Q4 2021 | $17,000 | -80.2% | 45,352 | -66.0% | 0.00% | -75.0% |
Q3 2021 | $86,000 | +855.6% | 133,484 | +947.4% | 0.01% | +700.0% |
Q2 2021 | $9,000 | -69.0% | 12,744 | -59.4% | 0.00% | -50.0% |
Q1 2021 | $29,000 | -19.4% | 31,364 | -40.0% | 0.00% | -50.0% |
Q4 2020 | $36,000 | +5.9% | 52,301 | +11.5% | 0.00% | -33.3% |
Q3 2020 | $34,000 | -26.1% | 46,903 | -34.1% | 0.01% | +50.0% |
Q4 2019 | $46,000 | +142.1% | 71,169 | +127.4% | 0.00% | +300.0% |
Q3 2019 | $19,000 | -86.9% | 31,291 | -63.5% | 0.00% | -88.9% |
Q2 2019 | $145,000 | – | 85,676 | – | 0.01% | – |
Download |